AcelRx Pharmaceuticals Stock Forecast, Price & News

AcelRx Pharmaceuticals (NASDAQ:ACRX) Frequently Asked Questions

Is AcelRx Pharmaceuticals a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AcelRx Pharmaceuticals in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AcelRx Pharmaceuticals stock.
View analyst ratings for AcelRx Pharmaceuticals or view top-rated stocks.

How has AcelRx Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

AcelRx Pharmaceuticals' stock was trading at $1.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ACRX shares have decreased by 58.6% and is now trading at $0.5053.
View which stocks have been most impacted by COVID-19.

When is AcelRx Pharmaceuticals' next earnings date?

AcelRx Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, March 21st 2022.
View our earnings forecast for AcelRx Pharmaceuticals.

How were AcelRx Pharmaceuticals' earnings last quarter?

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) posted its earnings results on Monday, November, 15th. The specialty pharmaceutical company reported ($0.07) EPS for the quarter, meeting the Zacks' consensus estimate of ($0.07). The specialty pharmaceutical company had revenue of $1.86 million for the quarter, compared to analysts' expectations of $1.20 million. During the same period in the prior year, the business earned ($0.10) EPS.
View AcelRx Pharmaceuticals' earnings history.

What price target have analysts set for ACRX?

1 brokers have issued 12 month price targets for AcelRx Pharmaceuticals' shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate AcelRx Pharmaceuticals' share price to reach $5.00 in the next year. This suggests a possible upside of 889.5% from the stock's current price.
View analysts' price targets for AcelRx Pharmaceuticals or view top-rated stocks among Wall Street analysts.

Who are AcelRx Pharmaceuticals' key executives?

AcelRx Pharmaceuticals' management team includes the following people:

• Vincent J. Angotti, Chief Executive Officer & Director
• Raffi Asadorian, Chief Financial & Accounting Officer
• Pamela Pierce Palmer, Director & Chief Medical Officer
• Badri N. Dasu, Chief Engineering Officer
• Mark A. Evashenk, Vice President-Clinical Operations

Who are some of AcelRx Pharmaceuticals' key competitors?

Some companies that are related to AcelRx Pharmaceuticals include Pieris Pharmaceuticals (PIRS), XOMA (XOMA), Antibe Therapeutics (ATBPD), Theratechnologies (THERF), Epizyme (EPZM), Citius Pharmaceuticals (CTXR), CTI BioPharma (CTIC), Capstar Special Purpose Acquisition (CPSR), Greenwich LifeSciences (GLSI), Harrow Health (HROW), Verrica Pharmaceuticals (VRCA), Magenta Therapeutics (MGTA), 89bio (ETNB), Summit Therapeutics (SMMT) and Biomea Fusion (BMEA).
View all of ACRX's competitors.

What other stocks do shareholders of AcelRx Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AcelRx Pharmaceuticals investors own include Advanced Micro Devices (AMD), Novavax (NVAX), Amarin (AMRN), Amicus Therapeutics (fold), Inovio Pharmaceuticals (INO), TG Therapeutics (TGTX), OPKO Health (OPK), CyberArk Software (CYBR), Flexion Therapeutics (FLXN) and NVIDIA (NVDA).

What is AcelRx Pharmaceuticals' stock symbol?

AcelRx Pharmaceuticals trades on the NASDAQ under the ticker symbol "ACRX."

How do I buy shares of AcelRx Pharmaceuticals?

Shares of ACRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AcelRx Pharmaceuticals' stock price today?

One share of ACRX stock can currently be purchased for approximately $0.51.

How much money does AcelRx Pharmaceuticals make?

AcelRx Pharmaceuticals has a market capitalization of $60.29 million and generates $5.42 million in revenue each year. The specialty pharmaceutical company earns $-40.38 million in net income (profit) each year or ($0.33) on an earnings per share basis.

How many employees does AcelRx Pharmaceuticals have?

AcelRx Pharmaceuticals employs 54 workers across the globe.

What is AcelRx Pharmaceuticals' official website?

The official website for AcelRx Pharmaceuticals is www.acelrx.com.

Where are AcelRx Pharmaceuticals' headquarters?

AcelRx Pharmaceuticals is headquartered at 351 GALVESTON DRIVE, REDWOOD CITY CA, 94063.

How can I contact AcelRx Pharmaceuticals?

AcelRx Pharmaceuticals' mailing address is 351 GALVESTON DRIVE, REDWOOD CITY CA, 94063. The specialty pharmaceutical company can be reached via phone at (650) 216-3500, via email at [email protected], or via fax at 650-216-6500.